Alvotech Under FDA Scrutiny After Routine Inspection
Following a routine facility inspection, Alvotech has received a Form 483 from the FDA, indicating potential issues that require attention.
Editorial Staff
1 min read
Updated 3 days ago
Alvotech, known by its ticker symbol ALVO, has come under scrutiny after a recent inspection by the FDA.
The inspection resulted in the issuance of a Form 483, which typically highlights concerns that the agency believes need to be addressed.
As the company navigates this regulatory challenge, it remains to be seen how it will respond to the findings outlined in the Form 483.